<?xml-stylesheet type='text/xsl' href='anzctrTransform.xsl'?>
<ANZCTR_Trial requestNumber="335566">
  <stage>Registered</stage>
  <submitdate>1/06/2010</submitdate>
  <approvaldate>1/12/2010</approvaldate>
  <actrnumber>ACTRN12610001056088</actrnumber>
  <trial_identification>
    <studytitle>Propofol or Ketofol for Emergency Medicine Procedural Sedation- A Randomised Controlled Trial utilising eHealth methodology.</studytitle>
    <scientifictitle>"Ketafol v Propofol in Emergency Department Procedural Sedation to reduce adverse events".</scientifictitle>
    <utrn />
    <trialacronym>POKEM Study</trialacronym>
    <secondaryid>QEMRF-PROJ-2010-028
Queensland Emergency Medicine Research foundation</secondaryid>
  </trial_identification>
  <conditions>
    <healthcondition>Emergency procedural sedation for painful conditions
eg fracture reductions, joint relocations</healthcondition>
    <conditioncode>
      <conditioncode1>Anaesthesiology</conditioncode1>
      <conditioncode2>Pain management</conditioncode2>
    </conditioncode>
    <conditioncode>
      <conditioncode1>Musculoskeletal</conditioncode1>
      <conditioncode2>Other muscular and skeletal disorders</conditioncode2>
    </conditioncode>
    <conditioncode>
      <conditioncode1>Injuries and Accidents</conditioncode1>
      <conditioncode2>Fractures</conditioncode2>
    </conditioncode>
  </conditions>
  <interventions>
    <interventions>This study will compare the use of a commonly used sedative drug  propofol, used alone or in combination with another drug that has sedative and pain relieving properties called ketamine. The idea is that using a combination of the two drugs together will result in lower doses of each being used if they were to be used independent of one another.
1) Initial Dose in ml equates to 0.5mg kg Propofol alone or 0.25mg/kg Ketamine and propofol in combination
2) Subsequent doses are at half those amounts minutely prn
3) The mode of administration is Intravenous injection.</interventions>
    <comparator>-Ketamine and Propofol combined v. Propofol alone
0.25mg/kg when combined v. 0.5 mg/kg  when propofol alone
-Subsequent doses at half the initial dose minutely
-IV route of administration
- Procedure usually complete within 10 -15 minutes but an average number of doses would be 4-5 including the initial and subsequent doses
- Ketafol is indeed a combination of ketamine and propofol</comparator>
    <control>Active</control>
    <interventioncode>Treatment: drugs</interventioncode>
  </interventions>
  <outcomes>
    <primaryOutcome>
      <outcome>Direct non invasive cardiorespiratory monitoring (oxygen saturation, pulse, respiratory rate, end tidal carbon dioxide and apnoea alarm) will be attached to the patient and as such a composite measure  of apnoea (failure of return of end tidal carbon dioxide (etCO2) trace for more than 15 seconds), hypoventilation (&lt;8 breaths/minute) or Oxygen saturation (O2 sat) &lt;93%, and the need for an intervention (airway opening manoeuvres or repositioning, airway adjuncts, manual ventilation, or intubation).</outcome>
      <timepoint>Baseline then the continously monitored variables will be written down every 3 minutes.</timepoint>
    </primaryOutcome>
    <secondaryOutcome>
      <outcome>Hypotension (SBP&lt;90mmHg) using a non invasive blood pressure cuff</outcome>
      <timepoint>3 minutely until end of treatment</timepoint>
    </secondaryOutcome>
    <secondaryOutcome>
      <outcome>Patient experience and satisfaction</outcome>
      <timepoint>post procedure</timepoint>
    </secondaryOutcome>
  </outcomes>
  <eligibility>
    <inclusivecriteria>Need for emergency department procedural sedation</inclusivecriteria>
    <inclusiveminage>18</inclusiveminage>
    <inclusiveminagetype>Years</inclusiveminagetype>
    <inclusivemaxage>75</inclusivemaxage>
    <inclusivemaxagetype>Years</inclusivemaxagetype>
    <inclusivegender>Both males and females</inclusivegender>
    <healthyvolunteer>No</healthyvolunteer>
    <exclusivecriteria>Inability to provide consent, age &lt;18yrs, pregnancy, soy or egg allergy, Glasgow Coma Scale&lt;15, hypotension, severe systemic disease (American  Society Anesthesiologists class IV or greater), uncontrolled hypertension (Blood Pressure&gt;160/90), patients with known Abdominal Aortic Aneurysm or symptomatic Ischaemic Heart Disease.</exclusivecriteria>
  </eligibility>
  <trial_design>
    <studytype>Interventional</studytype>
    <purpose>Treatment</purpose>
    <allocation>Randomised controlled trial</allocation>
    <concealment>Following provision of informed consent, patients will be randomised to receive either propofol alone, or ketofol. Each patient will be given a study pack which will contain data collection forms, patient information and consent sheets, as well as an opaque sealed envelope with the allocated treatment printed within.
Due to the instability of ketofol as a mixture, pre-mixing syringes is impractical. Therefore after enrolment a doctor within the Emergency Department, but not involved with the care of the patient will receive the sealed envelope containing a prescription for the study medication, and draw it up with a nurse within the Emergency Department (two practitioners necessary because of schedule 8 laws). 100mg of Study drug/s will be drawn up and diluted up to 20ml of Normal Saline, and then given to the sedationist, who will be blinded to the contents of the syringe. It will contain 5mg/ml of the study drug/s.</concealment>
    <sequence>Block randomisation will occur.</sequence>
    <masking>Blinded (masking used)</masking>
    <assignment>Parallel</assignment>
    <designfeatures />
    <endpoint>Safety</endpoint>
    <statisticalmethods />
    <masking1 />
    <masking2 />
    <masking3 />
    <masking4 />
    <patientregistry />
    <followup />
    <followuptype />
    <purposeobs />
    <duration />
    <selection />
    <timing />
  </trial_design>
  <recruitment>
    <phase>Not Applicable</phase>
    <anticipatedstartdate>1/02/2011</anticipatedstartdate>
    <actualstartdate />
    <anticipatedenddate />
    <actualenddate />
    <samplesize>350</samplesize>
    <actualsamplesize />
    <recruitmentstatus>Not yet recruiting</recruitmentstatus>
    <recruitmentcountry>Australia</recruitmentcountry>
    <recruitmentstate />
  </recruitment>
  <sponsorship>
    <primarysponsortype>Hospital</primarysponsortype>
    <primarysponsorname>QE II Hospital</primarysponsorname>
    <primarysponsoraddress>c/o Emergency Department, 
QE II Jubilee Hospital, 
cnr Troughton and Kessels Rd, Coopers Plains, QLD 4108</primarysponsoraddress>
    <primarysponsorcountry>Australia</primarysponsorcountry>
    <fundingsource>
      <fundingtype>Charities/Societies/Foundations</fundingtype>
      <fundingname>Queensland Emergency Medicine Research Foundation</fundingname>
      <fundingaddress>Queensland Emergency Medicine Research Foundation
Courier: iLab, Level 1, 80 Jephson St, Toowong, QLD 4066
Mail: PO Box 2199, Toowong, QLD 4066.</fundingaddress>
      <fundingcountry>Australia</fundingcountry>
    </fundingsource>
    <secondarysponsor>
      <sponsortype>Hospital</sponsortype>
      <sponsorname>Bundaberg Hospital</sponsorname>
      <sponsoraddress>Bourbong Street BUNDABERG QLD 4670 
Postal Address: PO BOX 34 BUNDABERG QLD 4670</sponsoraddress>
      <sponsorcountry>Australia</sponsorcountry>
    </secondarysponsor>
  </sponsorship>
  <ethicsAndSummary>
    <summary />
    <trialwebsite />
    <publication />
    <ethicsreview>Not yet submitted</ethicsreview>
    <publicnotes />
    <ethicscommitee>
      <ethicname>Princess Alexandra Hospital Ethics Committee</ethicname>
      <ethicaddress>Princess Alexandra Hospital 
Ipswich Rd
Wooloongabba 4102 QLD</ethicaddress>
      <ethicapprovaldate />
      <hrec>HREC/10/QPAH/235</hrec>
      <ethicsubmitdate>14/10/2010</ethicsubmitdate>
      <ethiccountry>Australia</ethiccountry>
    </ethicscommitee>
  </ethicsAndSummary>
  <attachment />
  <contacts>
    <contact>
      <title />
      <name>Anthony Bell</name>
      <address>C/O ED
QE II Jubilee Hospital
cnr Kessels Rd and Troughton Rd 
Coopers Plains 4108
QLD</address>
      <phone>+61 7 31374511</phone>
      <fax />
      <email>anthony_bell@health.qld.gov.au</email>
      <country>Australia</country>
      <type>Scientific Queries</type>
    </contact>
    <contact>
      <title />
      <name>Anthony Bell</name>
      <address>C/O ED
QE II Jubilee Hospital
cnr Kessels Rd and Troughton Rd 
Coopers Plains 4108
QLD</address>
      <phone>+61 7 31374511</phone>
      <fax />
      <email>anthony_bell@health.qld.gov.au</email>
      <country>Australia</country>
      <type>Public Queries</type>
    </contact>
    <contact>
      <title />
      <name>Anthony Bell</name>
      <address>C/O ED
QE II Jubilee Hospital
cnr Kessels Rd and Troughton Rd 
Coopers Plains 4108
QLD</address>
      <phone>+61 7 31374511</phone>
      <fax />
      <email>anthony_bell@health.qld.gov.au</email>
      <country />
      <type>Updating Information</type>
    </contact>
    <contact>
      <title />
      <name />
      <address />
      <phone />
      <fax />
      <email />
      <country />
      <type>Principal Investigator</type>
    </contact>
  </contacts>
</ANZCTR_Trial>